pemetrexed,paclitaxel,cisplatin,vinorelbine,nivolumab,pembrolizumab,docetaxel,carboplatin,gemcitabine,ipilimumab,durvalumab
merck,bms,astrazeneca
['cm816', 'kn671', 'nsclc', 'ts,perio,1', 'pembro', 'sclc', 'ts,perio,i', 'lcsm,(-blcsm)']
1. #kn671: neoadj chemo + periop #pembrolizumab in stage ii/iiia/iiib (n2) nsclc: - efs 62.4% (hr 0.58) at 24mo
- pcr 18.1 vs 4.0% - ~20% did not make it to surgery #asco23 #lcsm - who gets cm816 vs. #aegan vs #kn671? 2/4 
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE